-
SALE
IN STOCK
ANTIANGIOGENIC AGENTS IN CANCER THERAPYOriginal price was: ₹21,819.00.₹17,455.00Current price is: ₹17,455.00. -
SALE
IN STOCK
CANCER DRUG RESISTANCE (HB) (Cancer Drug Discovery and Development)Original price was: ₹24,859.00.₹16,158.00Current price is: ₹16,158.00.